174 related articles for article (PubMed ID: 27234782)
1. Low Incidence of Malignancy After Heart Transplantation in Taiwan.
Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
Transplant Proc; 2016 Apr; 48(3):974-7. PubMed ID: 27234782
[TBL] [Abstract][Full Text] [Related]
2. Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression.
Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
Transplant Proc; 2016 Apr; 48(3):969-73. PubMed ID: 27234781
[TBL] [Abstract][Full Text] [Related]
3. Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.
Doesch AO; Müller S; Konstandin M; Celik S; Kristen A; Frankenstein L; Ehlermann P; Sack FU; Katus HA; Dengler TJ
Transplant Proc; 2010 Nov; 42(9):3694-9. PubMed ID: 21094840
[TBL] [Abstract][Full Text] [Related]
4. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
Rivinius R; Helmschrott M; Ruhparwar A; Schmack B; Klein B; Erbel C; Gleissner CA; Akhavanpoor M; Frankenstein L; Darche FF; Thomas D; Ehlermann P; Bruckner T; Katus HA; Doesch AO
Drug Des Devel Ther; 2015; 9():93-102. PubMed ID: 25552900
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of malignancy in heart-transplant recipients in Taiwan: an update and comparison with kidney-transplant recipients.
Hsu RB; Chang CI; Tsai MK; Lee PH; Chou NK; Chi NH; Wang SS; Chu SH
Eur J Cardiothorac Surg; 2010 May; 37(5):1117-21. PubMed ID: 20045346
[TBL] [Abstract][Full Text] [Related]
6. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation.
O'Neill JO; Edwards LB; Taylor DO
J Heart Lung Transplant; 2006 Oct; 25(10):1186-91. PubMed ID: 17045930
[TBL] [Abstract][Full Text] [Related]
8. A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population.
Higgins RS; Brown RN; Chang PP; Starling RC; Ewald GA; Tallaj JA; Kirklin JK; George JF
J Heart Lung Transplant; 2014 May; 33(5):478-85. PubMed ID: 24630406
[TBL] [Abstract][Full Text] [Related]
9. Malignancy after heart transplantation.
Chen PL; Chang HH; Chen IM; Lai ST; Shih CC; Weng ZC; Hsieh YC; Yang AH
J Chin Med Assoc; 2009 Nov; 72(11):588-93. PubMed ID: 19948436
[TBL] [Abstract][Full Text] [Related]
10. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
11. Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry.
Crespo-Leiro MG; Alonso-Pulpón L; Arizón JM; Almenar L; Delgado JF; Palomo J; Manito N; Rábago G; Lage E; Diaz B; Roig E; Pascual D; Blasco T; de la Fuente L; Campreciós M; Vázquez de Prada JA; Muñiz J
J Heart Lung Transplant; 2007 Nov; 26(11):1105-9. PubMed ID: 18022075
[TBL] [Abstract][Full Text] [Related]
12. Malignancy after renal transplantation in the new era of immunosuppression.
Watorek E; Boratynska M; Smolska D; Patrzalek D; Klinger M
Ann Transplant; 2011; 16(2):14-8. PubMed ID: 21716180
[TBL] [Abstract][Full Text] [Related]
13. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
14. High rates of de novo malignancy compromise post-heart transplantation survival.
Giuliano K; Canner JK; Etchill E; Suarez-Pierre A; Choi CW; Higgins RSD; Hsu S; Sharma K; Kilic A
J Card Surg; 2021 Apr; 36(4):1401-1410. PubMed ID: 33567114
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy.
Caforio AL; Fortina AB; Piaserico S; Alaibac M; Tona F; Feltrin G; Pompei E; Testolin L; Gambino A; Volta SD; Thiene G; Casarotto D; Peserico A
Circulation; 2000 Nov; 102(19 Suppl 3):III222-7. PubMed ID: 11082391
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
17. De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor.
Chen KH; Lee CY; Wu FL; Yang CY; Yeh CC; Hu RH; Tsai MK
J Formos Med Assoc; 2015 Jun; 114(6):526-31. PubMed ID: 25843527
[TBL] [Abstract][Full Text] [Related]
18. Malignancy following renal transplantation.
Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
[TBL] [Abstract][Full Text] [Related]
19. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
[TBL] [Abstract][Full Text] [Related]
20. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function.
Garrido IP; Crespo-Leiro MG; Paniagua MJ; Muñiz J; Vázquez-Rey E; Pérez-Fernández R; García-Lara J; Cuenca-Castillo JJ; Castro-Beiras A
J Heart Lung Transplant; 2005 Sep; 24(9):1226-30. PubMed ID: 16143237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
